Cargando…
Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study
Currently, the choice of medical treatment for major depressive disorder (MDD) is primarily based on a trial-and-error process. Thus, identification of individual factors capable of predicting treatment response is of great clinical relevance. Recent work points towards beclin-1 and inflammatory fac...
Autores principales: | He, Shen, Zeng, Duan, Xu, Feikang, Zhang, Jianping, Zhao, Nan, Wang, Qiang, Shi, Jiali, Lin, Zhiguang, Yu, Wenjuan, Li, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563849/ https://www.ncbi.nlm.nih.gov/pubmed/31244689 http://dx.doi.org/10.3389/fpsyt.2019.00378 |
Ejemplares similares
-
The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021) -
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
por: Arteaga-Henríquez, Gara, et al.
Publicado: (2019) -
A Possible Common Neurophysiologic Basis for MDD, Bipolar Disorder, and Schizophrenia: Lessons from Electrophysiology
por: Shahaf, Goded
Publicado: (2016) -
Enhanced Functional Connectivity Within Executive Function Network in Remitted or Partially Remitted MDD Patients
por: Wang, Yuchen, et al.
Publicado: (2021) -
The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
por: Waters, Kristin
Publicado: (2022)